<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02835443</url>
  </required_header>
  <id_info>
    <org_study_id>REDD 0002</org_study_id>
    <nct_id>NCT02835443</nct_id>
  </id_info>
  <brief_title>Electrical Stimulation of the Dentate Nucleus for Upper Extremity Hemiparesis Due to Ischemic Stroke</brief_title>
  <acronym>EDEN</acronym>
  <official_title>Electrical Stimulation of the Dentate Nucleus Area (EDEN) for Improvement of Upper Extremity Hemiparesis Due to Ischemic Stroke: A Safety and Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Enspire DBS Therapy, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Enspire DBS Therapy, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial will evaluate if Deep Brain Stimulation (DBS) is safe for the treatment&#xD;
      of stroke and will help understand if DBS improves motor recovery for patients who continue&#xD;
      to have significant impairment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed study is a safety and feasibility study intended to provide preliminary data to&#xD;
      design a future pilot study. The objective of this study is to document the safety and&#xD;
      patient outcomes of electrical stimulation of the dentate nucleus area for the management of&#xD;
      chronic, moderate to severe upper extremity hemiparesis due to ischemic stroke.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>18 Months</time_frame>
    <description>Incidence of all serious adverse events</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Electrical Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This is a single arm study and all subjects will receive electrical stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep Brain Stimulation</intervention_name>
    <description>Electrical stimulation of the dentate nucleus area of the cerebellum.</description>
    <arm_group_label>Electrical Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          -  One-time stroke that occurred 1-3 years ago (i.e. index stroke 12-36 months)&#xD;
&#xD;
          -  Stroke due to a blocked blood vessel (i.e. unilateral MCA stroke)&#xD;
&#xD;
          -  Moderate to severe weakness in one arm (i.e. unilateral upper-extremity hemiparesis)&#xD;
&#xD;
        Key Exclusion Criteria:&#xD;
&#xD;
          -  Seizures since time of stroke (i.e. seizures or seizure disorder)&#xD;
&#xD;
          -  Unable to have an MRI (i.e. contraindicated for MRI)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andre Machado, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>July 7, 2016</study_first_submitted>
  <study_first_submitted_qc>July 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2016</study_first_posted>
  <last_update_submitted>February 4, 2021</last_update_submitted>
  <last_update_submitted_qc>February 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ischemic Stroke</keyword>
  <keyword>Deep Brain Stimulation</keyword>
  <keyword>DBS</keyword>
  <keyword>Physical Therapy</keyword>
  <keyword>Rehab</keyword>
  <keyword>Brain Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Paresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

